s6y
Company name or ticker
Search
RVL Pharmaceuticals plc
ARS
Annual report to security holders
Filed
Monday, April 24, 2023
Period
Dec 31, 2022
Accession number
0001104659-23-049003
Documents
ARS
ARS
On sec.gov
Filing index
All files
Complete submission text
SGML header